Ted Okon the Executive Director of the Community Oncology Alliance (COA) on When the Value-Based Insurance Design Will be Implemented
OncLive TV
Patrick W. Cobb, MD, FACP the President of the Community Oncology Alliance (COA) Discusses Community Oncology Across the Country
Advertisement
E. David Crawford, MD from the University of Colorado Health Sciences Center Talks About 3D Mapping Biopsies
Ted Okon the Executive Director of the Community Oncology Alliance (COA) Discusses the Challenges of the Value-Based Insurance Design
Dr. Leonard Gomella from the Jefferson Kimmel Cancer Center on Novel Prostate Cancer Immunotherapies
Advertisement
Dr. Edith Perez from the Mayo Clinic in Florida on Adjuvant Treatments for Breast Cancer
Healthcare Reform
Disparities in the Healthcare System
Dr. Howard Sandler from Cedars-Sinai Medical Center discusses the TAK-700 in Localized Prostate Cancer Clinical Trials
Christopher Twelves, MD, Professor of Clinical Cancer Pharmacology and Oncology and Head of the Clinical Cancer Research Group at the University of Leeds in the United Kingdom on the Value of the Negative Iniparib Trial Results
Robert Dreicer, MD, from the Taussig Cancer Institute, Discusses How New Treatments Have Improved Survival
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD
3
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
4
Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer
5